The US stock markets' increasing value is not seen as a favorable sign while international exchanges are dwindling.
All-time highs for Dow Jones, which have become a trend in 2017, is not likely to continue in the future.
Defense and security stocks will benefit from beefing up the military's infrastructure, training, weaponry, and technology.
The demand for zinc is expected to increase in the next few years due to the higher interest in electric cars.
Water infrastructure projects should be a top priority in the US but Congress is still in the process of deliberating the funding.
PharmAthene, Inc. and Northrop Grumman Corporation are two of the top biosecurity companies in 2017.
While some BRIC countries lived up to their potential, others fell from the burden of expectations.
Trump's long-awaited infrastructure plan could be in peril with the elimination of PABs.
Venture capital will remain to be significant next year amid challenges on innovation in the sector.
The global economy is expected to grow once again next year.